Surfactant replacement therapy in preterm infants: A European survey

Neonatology

Volumn 100, Issue 1, 2011, Pages 71-77

  Van Kaam, Anton H ^a   De Jaegere, Anne P ^a   Borensztajn, Dorine ^a   Rimensberger, Peter C ^b  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Best practice guidelines; Mechanical ventilation; Preterm infant; Surfactant

Indexed keywords

SURFACTANT;

ARTIFICIAL VENTILATION; CLINICAL PRACTICE; GESTATIONAL AGE; HEALTH SURVEY; HUMAN; INFANT; MAJOR CLINICAL STUDY; NEWBORN INTENSIVE CARE; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; REVIEW;

CHEMOPREVENTION; DATA COLLECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; INTERNATIONAL COOPERATION; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

ANIMALIA;

EID: 78651246300     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000322004     Document Type: Review

References (12)

1. Soll R, Özek E: Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 1997; 4: CD000511
2. Soll RF, Morley CJ: Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001; 2: CD000510.
3. Yost CC, Soll RF: Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 1999; 4: CD001456.
4. Soll RF, Blanco F: Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001; 2: CD000144.
5. Soll RF: Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2009; 1: CD000141.
6. Morley C, Davis P: Surfactant treatment for premature lung disorders: a review of best practices in 2002. Paediatr Respir Rev 2004; 5(suppl A): S299-S304.
7. Engle WA: Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008; 121: 419-432. (Pubitemid 351198470)
8. Sweet D, Bevilacqua G, Carnielli V, Greisen G, Plavka R, Didrik SO, Simeoni U, Speer CP, Valls IS, Halliday H, Working Group on Prematurity of the World Association of Perinatal Medicine, European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome. J Perinat Med 2007; 35: 175-186. (Pubitemid 46700981)
9. Horbar JD, Carpenter JH, Buzas J, Soll RF, Suresh G, Bracken MB, Leviton LC, Plsek PE, Sinclair JC: Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based? Pediatrics 2004; 113: 1593-1602. (Pubitemid 38697964)
10. Verder H, Robertson B, Greisen G, Ebbesen F, Albertsen P, Lundstrom K, Jacobsen T: Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. N Engl J Med 1994; 331: 1051-1055. (Pubitemid 24317697)
11. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, Mosca F, Nona J, Thomson M, Verder H, Fabbri L, Halliday H: Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010; 125: e1402-e1409.
12. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB: Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008; 358: 700-708. (Pubitemid 351240749)